Jason Grady is Director at IMPACT BIOMEDICAL INC. (IBO). They have made 1 open-market trade across 1 company since 2026, most recently 2026-03-23.
CIK 0001782482
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IBO | 250,182 | $1.1M |
| DSS | 74,770 | $46K |
| Total | $1.1M |
Shares reported on the most recent Form 4, priced at the 2026-03-25 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IBO | SELL | 2026-03-23 | 2026-03-25 | $0.65 | $65K | +20.2% | +17.2% | -4.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.